DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Jänne PA, von Pawel J, Cohen RB et al.
Multicenter, randomized, phase II trial of CI-1033, an irreversible pan-ERBB inhibitor, for previously treated advanced non small-cell lung cancer.
J Clin Oncol 2007;
25: 3936-3944
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.